文献速递前列腺癌

含发酵大豆的营养补充剂用于前列腺癌风险升高且前列腺活检阴性男性的研究:前瞻性PRAECAP试验的总体与肿瘤学结果

Nutritional Supplement With Fermented Soy in Men With an Elevated Risk of Prostate Cancer and Negative Prostate Biopsies: General and Oncological Results From the Prospective PRAECAP Trial.
PubMed 文献 · Urology · 2024-04-25

PRAECAP前瞻性试验纳入94例前列腺癌风险升高且既往活检阴性的男性,给予含发酵大豆的营养补充剂6个月。81%的患者出现PSA反应,25.8%(24/93)的患者IPSS下降至少3分,前列腺体积中位数无统计学变化(P=.908)。PSA发生调节的患者接受更少检查、阳性活检更少(P<.001)且ISUP≥3病变显著更少(P=.02)。

要点

  • 94例前列腺癌风险升高且既往活检阴性男性接受含发酵大豆补充剂6个月
  • 81%患者出现PSA反应,25.8%(24/93)IPSS下降至少3分
  • 前列腺体积中位数6个月后无统计学变化(P=.908)

核心结论

  • 含发酵大豆补充剂6个月后观察到PSA水平显著降低,并在部分患者中对IPSS产生效果。
  • 作者认为,对前列腺癌风险升高的患者处方含发酵大豆补充剂可能有助于更好地筛选真正存在隐匿性前列腺癌风险的患者。

研究设计与样本

  • 前瞻性PRAECAP试验,纳入94例可分析患者。
  • 入组标准为前列腺癌风险升高,定义为以下任一:PSA>3 ng/mL、直肠指检(DRE)可疑病变、经直肠超声(TRUS)/磁共振成像(MRI)可疑病变,且入组前12个月内既往前列腺活检阴性(至少8针)。
  • 统计分析采用非参数单侧配对Wilcoxon秩和检验、卡方检验和Fisher精确检验。

主要发现

  • 81%的病例检测到PSA反应。
  • 25.8%(24/93)的患者观察到IPSS下降至少3分。
  • 6个月后前列腺体积中位数无统计学变化(P=.908)。
  • PSA发生调节的患者接受更少检查,阳性活检更少(P<.001),且ISUP≥3病变显著更少(P=.02)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the effect of a dietary supplement containing fermented soy on PSA, IPSS, changes in prostate volume and prostate cancer (PCa) development after a 6-month challenge in men at increased risk of PCa and negative previous biopsies. MATERIALS AND METHODS: Patients with an elevated risk of PCa, defined by either 1 of the following criteria: PSA >3 ng/mL, suspect lesion at digital rectal examination (DRE), suspect lesion at transrectal ultrasound (TRUS)/magnetic resonance imaging (MRI) and previous negative prostate biopsies (at least 8 cores) within 12 months before inclusion. Statistical analysis was carried out using a non-parametric 1-sided paired Wilcoxon rank sum test, chi-square test, and Fisher's exact test. RESULTS: In this trial, 94 patients were eligible for analysis. A PSA response was detected in 81% of the cases. In 25.8% (24/93) of patients, a decrease of at least 3 points on the IPSS was observed. The median prostate volume did not statistically change after 6 months (P = .908). Patients with PSA modulation required fewer investigations and had fewer positive biopsies (P <.001) and significantly fewer ISUP ≥3 lesions (P = .02). CONCLUSION: We observed a significantly lower PSA level after a 6-month challenge with a fermented soy-containing supplement, and an effect on IPSS in a subset of patients. Prescribing a fermented soy supplement in patients with an increased PCa risk could lead to a better selection of patients at real increased risk of having occult PCa.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Van Der Eecken H, Vansevenant B, Devos G, et al. Nutritional Supplement With Fermented Soy in Men With an Elevated Risk of Prostate Cancer and Negative Prostate Biopsies: General and Oncological Results From the Prospective PRAECAP Trial. Urology. 2024. PMID: 38670272. doi:10.1016/j.urology.2024.04.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。